194 related articles for article (PubMed ID: 18701818)
1. Circulating matrix metalloproteinase-2 is an independent correlate of proteinuria in patients with chronic kidney disease.
Nagano M; Fukami K; Yamagishi S; Ueda S; Kaida Y; Matsumoto T; Yoshimura J; Hazama T; Takamiya Y; Kusumoto T; Gohara S; Tanaka H; Adachi H; Okuda S
Am J Nephrol; 2009; 29(2):109-15. PubMed ID: 18701818
[TBL] [Abstract][Full Text] [Related]
2. Determinants of circulating matrix metalloproteinase-2 and pregnancy-associated plasma protein-A in patients with chronic kidney disease.
Zakiyanov O; Kalousová M; Kratochvilová M; Kríha V; Zima T; Tesar V
Clin Lab; 2012; 58(5-6):471-80. PubMed ID: 22783577
[TBL] [Abstract][Full Text] [Related]
3. Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease.
Chang HR; Yang SF; Li ML; Lin CC; Hsieh YS; Lian JD
Clin Chim Acta; 2006 Apr; 366(1-2):243-8. PubMed ID: 16313894
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type plasminogen activator and metalloproteinase-2 are independently related to the carotid atherosclerosis in haemodialysis patients.
Pawlak K; Pawlak D; Myśliwiec M
Thromb Res; 2008; 121(4):543-8. PubMed ID: 17706748
[TBL] [Abstract][Full Text] [Related]
6. The role of matrix metalloproteinases 2 in atherosclerosis of patients with chronic kidney disease in type 2 diabetes.
Soliman AR; Sadek KM; Thabet KK; Ahmed DH; Mohamed OM
Saudi J Kidney Dis Transpl; 2019; 30(2):387-393. PubMed ID: 31031375
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
8. MMP and TIMP alterations in asymptomatic and symptomatic severe recurrent carotid artery stenosis.
Sapienza P; Borrelli V; di Marzo L; Cavallaro A
Eur J Vasc Endovasc Surg; 2009 May; 37(5):525-30. PubMed ID: 19297218
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction.
Mitsnefes M; Kartal J; Khoury P; Daniels S
Clin J Am Soc Nephrol; 2007 Jan; 2(1):46-50. PubMed ID: 17699386
[TBL] [Abstract][Full Text] [Related]
10. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
11. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
Peiskerová M; Kalousová M; Kratochvílová M; Dusilová-Sulková S; Uhrová J; Bandúr S; Malbohan IM; Zima T; Tesar V
Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911
[TBL] [Abstract][Full Text] [Related]
13. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
14. Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease.
Tang X; Chen M; Zhang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 38(6):553-9. PubMed ID: 23828708
[TBL] [Abstract][Full Text] [Related]
15. [Survey of risk factors and renal disease in first-degree relatives of dialysis patients].
Inserra F; de la Llave G; Alpino M; Castagna R; de la Fuente I; Dorado E; Norbis M; Pinelli L; Puddu M; Santos JC; Vivas N; Marelli C
Medicina (B Aires); 2007; 67(1):8-18. PubMed ID: 17408015
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for chronic kidney disease in patients with coronary artery disease.
Bao YS; Na SP; Jia XB; Liu RC; Wang MA; Yu CY; Mu SH; Xie RJ
Curr Med Res Opin; 2012 Mar; 28(3):379-84. PubMed ID: 22335251
[TBL] [Abstract][Full Text] [Related]
17. Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease.
Nanayakkara PW; Kiefte-de Jong JC; Stehouwer CD; van Ittersum FJ; Olthof MR; Kok RM; Blom HJ; van Guldener C; ter Wee PM; Smulders YM
Nephrol Dial Transplant; 2008 Aug; 23(8):2586-92. PubMed ID: 18287179
[TBL] [Abstract][Full Text] [Related]
18. Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis.
Zalba G; Fortuño A; Orbe J; San José G; Moreno MU; Belzunce M; Rodríguez JA; Beloqui O; Páramo JA; Díez J
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):587-93. PubMed ID: 17194891
[TBL] [Abstract][Full Text] [Related]
19. Negative association between serum levels of matrix metalloproteinases-2 and -9 and aortic stiffness in healthy adults.
Vlachopoulos C; Aznaouridis K; Dima I; Ioakeimidis N; Vasiliadou C; Zervoudaki A; Gialernios T; Stefanadis C
Int J Cardiol; 2007 Nov; 122(3):232-8. PubMed ID: 17289174
[TBL] [Abstract][Full Text] [Related]
20. Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression.
Sapienza P; di Marzo L; Borrelli V; Sterpetti AV; Mingoli A; Piagnerelli R; Cavallaro A
Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):89-97. PubMed ID: 15177237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
